MDPI and ACS Style
Fanta, B.S.; Lenjisa, J.; Teo, T.; Kou, L.; Mekonnen, L.; Yang, Y.; Basnet, S.K.C.; Hassankhani, R.; Sykes, M.J.; Yu, M.;
et al. Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation. Molecules 2023, 28, 2951.
https://doi.org/10.3390/molecules28072951
AMA Style
Fanta BS, Lenjisa J, Teo T, Kou L, Mekonnen L, Yang Y, Basnet SKC, Hassankhani R, Sykes MJ, Yu M,
et al. Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation. Molecules. 2023; 28(7):2951.
https://doi.org/10.3390/molecules28072951
Chicago/Turabian Style
Fanta, Biruk Sintayehu, Jimma Lenjisa, Theodosia Teo, Lianmeng Kou, Laychiluh Mekonnen, Yuchao Yang, Sunita K. C. Basnet, Ramin Hassankhani, Matthew J. Sykes, Mingfeng Yu,
and et al. 2023. "Discovery of N,4-Di(1H-pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation" Molecules 28, no. 7: 2951.
https://doi.org/10.3390/molecules28072951